ALBT - Avalon GloboCare Corp.
0.867
-0.110 -12.710%
Share volume: 988,065
Last Updated: 03-05-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$0.98
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-30-2024 | 08-19-2024 | 11-12-2024 | 05-13-2025 | 08-14-2025 | 11-14-2025 | |
| Total revenue | 314.588 K | 327.887 K | 345.159 K | 349.800 K | 350.406 K | 350.099 K | |
| Cost of revenue | 0.000 | 0.000 | 343.360 K | 0.000 | 1.974 M | -1.420 M | |
| Gross profit | 314.588 K | 327.887 K | 1.799 K | 349.800 K | -1.624 M | 1.770 M | |
| 4.23% | -99.45% | 19,344.14% | -564.16% | 209.00% | |||
| Operating expenses | 956.993 K | 1.155 M | 433.589 K | 2.198 M | 5.678 M | 1.554 M | |
| Selling general and admin | 956.993 K | 1.155 M | 433.589 K | 2.198 M | 5.678 M | 1.554 M | |
| Research and development | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total expenses | 263.126 K | 285.488 K | 724.220 K | 280.390 K | 6.152 M | 1.922 M | |
| 8.50% | 153.68% | -61.28% | 2,094.21% | -68.76% | |||
| Operating income | -843.062 K | -1.504 M | -1.270 M | -1.807 M | -3.888 M | -76.193 K | |
| Ebit | -843.062 K | -1.505 M | -1.132 M | -1.807 M | -12.895 M | -164.935 K | |
| Pretax income | -1.368 M | -2.132 M | -1.679 M | -2.482 M | -13.459 M | -254.268 K | |
| 55.91% | -21.24% | 47.82% | 442.22% | -98.11% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -959.601 K | -2.132 M | -1.679 M | -2.482 M | -26.917 M | -508.536 K | |
| -122.18% | 21.24% | -47.82% | -984.45% | 98.11% |